PEMBROKE, BERMUDA, September 28 /CNW/ - Covidien Ltd. (NYSE: COV; BSX:
COV) announced today that its Board of Directors has declared a quarterly cash
dividend of $0.16 per common share. The dividend is payable on November 9,
2007 to shareholders of record on October 9, 2007.
"This declaration, our first dividend as a public company, is an
important milestone for the Company and its investors," said President and
Chief Executive Officer Richard J. Meelia.
ABOUT COVIDIEN LTD.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers value
through clinical leadership and excellence. Covidien manufactures, distributes
and services a diverse range of industry-leading product lines, including
Surgical Devices, Energy-based Devices, Respiratory and Monitoring Solutions,
Patient Care and Safety Products, Imaging Solutions, Pharmaceutical Products,
Medical Supplies and Retail Products. With 2006 revenue of nearly $10 billion,
Covidien has more than 43,000 employees worldwide in 57 countries, and its
products are sold in over 130 countries. For additional information, please
visit our website, www.covidien.com.
For further information:
For further information: Covidien Ltd. Eric Kraus, 508-261-8305 Senior
Vice President Corporate Communications firstname.lastname@example.org or Coleman
Lannum, CFA, 508-452-4343 Vice President Investor Relations
email@example.com or Bruce Farmer, 508-452-4372 Director Financial
Communications firstname.lastname@example.org or Wayde McMillan, 508-452-4387
Director Investor Relations email@example.com